

MCQOPTIONS
Saved Bookmarks
1. |
Which of the following is the first non-factor prophylactic bypassing agent that was recently approved for haemophilia A patients with and without inhibitors? |
A. | Tocilizumab |
B. | Itolizumab |
C. | Hemilizumab |
D. | Emicizumab |
Answer» E. | |